Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSyndax Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

Syndax Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Jul 8, 2026Metzger Michael AChief Executive Officer32,375Stock Option (Right to buy)—Option exercise
Jul 8, 2026Metzger Michael AChief Executive Officer32,375Common Stock—Sell
Jul 8, 2026Metzger Michael AChief Executive Officer32,375Common Stock—Exercise / conversion
Jun 12, 2026Botwood Nicholas A.J.Head of R&D, CMO31,235Stock options (Right to buy)—Option exercise
Jun 12, 2026Botwood Nicholas A.J.Head of R&D, CMO31,235Common Stock—Sell
Jun 12, 2026Botwood Nicholas A.J.Head of R&D, CMO31,235Common Stock—Exercise / conversion
Jun 11, 2026Botwood Nicholas A.J.Head of R&D, CMO22,515Stock options (Right to buy)—Option exercise
Jun 11, 2026Botwood Nicholas A.J.Head of R&D, CMO34,280Common Stock—Sell
Jun 11, 2026Botwood Nicholas A.J.Head of R&D, CMO22,515Common Stock—Exercise / conversion
Jun 1, 2026Metzger Michael AChief Executive Officer6,847Common Stock—Sell
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions